These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 30431421)

  • 21. Bacterial Keratitis in Toronto: A 16-Year Review of the Microorganisms Isolated and the Resistance Patterns Observed.
    Tam ALC; Côté E; Saldanha M; Lichtinger A; Slomovic AR
    Cornea; 2017 Dec; 36(12):1528-1534. PubMed ID: 28938380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Profile and antibiotic susceptibility of 5187 uropathogenic bacteria in Tunisia].
    Marzouk M; Toumi N; Ben Hadj Hassine A; Haj Ali M; Boukadida J
    Med Mal Infect; 2016 Sep; 46(6):330-2. PubMed ID: 27318607
    [No Abstract]   [Full Text] [Related]  

  • 23. Pattern of Polymicrobial Isolates and Antimicrobial Susceptibility from Blood.
    Shabbir S; Jamil S; Hafiz S
    J Coll Physicians Surg Pak; 2016 Jul; 26(7):585-8. PubMed ID: 27504550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Widespread Fosfomycin Resistance in Gram-Negative Bacteria Attributable to the Chromosomal
    Ito R; Mustapha MM; Tomich AD; Callaghan JD; McElheny CL; Mettus RT; Shanks RMQ; Sluis-Cremer N; Doi Y
    mBio; 2017 Aug; 8(4):. PubMed ID: 28851843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution and antimicrobial resistance of clinical and subclinical mastitis pathogens in dairy cows in Rhône-Alpes, France.
    Botrel MA; Haenni M; Morignat E; Sulpice P; Madec JY; Calavas D
    Foodborne Pathog Dis; 2010 May; 7(5):479-87. PubMed ID: 19919286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001).
    Streit JM; Jones RN; Sader HS; Fritsche TR
    Int J Antimicrob Agents; 2004 Aug; 24(2):111-8. PubMed ID: 15288308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First point prevalence survey of nosocomial infections in the intensive care units of a tertiary care hospital in Albania.
    Faria S; Sodano L; Dauri M; Sabato AF; Gjata A; Kito I; Llazo E; Bilaj A; Mertiraj O; Schinaia N;
    J Hosp Infect; 2008 May; 69(1):95-7. PubMed ID: 18346815
    [No Abstract]   [Full Text] [Related]  

  • 28. Mechanisms of β-lactam antimicrobial resistance and epidemiology of major community- and healthcare-associated multidrug-resistant bacteria.
    Tang SS; Apisarnthanarak A; Hsu LY
    Adv Drug Deliv Rev; 2014 Nov; 78():3-13. PubMed ID: 25134490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fosfomycin in severe infections due to genetically distinct pan-drug-resistant Gram-negative microorganisms: synergy with meropenem.
    Perdigão Neto LV; Oliveira MS; Martins RCR; Marchi AP; Gaudereto JJ; da Costa LATJ; de Lima LFA; Takeda CFV; Costa SF; Levin AS
    J Antimicrob Chemother; 2019 Jan; 74(1):177-181. PubMed ID: 30376073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survey of the susceptibility of urinary isolates to antibacterial agents in 2003.
    Ishikawa K; Hayakawa S; Miyakawa S; Kusaka M; Shiroki R; Hoshinaga K
    J Infect Chemother; 2005 Feb; 11(1):44-7. PubMed ID: 15729488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging Gram negative resistance to last-line antimicrobial agents fosfomycin, colistin and ceftazidime-avibactam - epidemiology, laboratory detection and treatment implications.
    Sherry N; Howden B
    Expert Rev Anti Infect Ther; 2018 Apr; 16(4):289-306. PubMed ID: 29543500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Surveillance of antimicrobial resistance of bacteria isolated from bloodstream infections: data of the French National Observatory for Epidemiology of Bacterial Resistance to Antibiotics (ONERBA), 1998-2003].
    Bertrand X; Costa Y; Pina P
    Med Mal Infect; 2005 Jun; 35(6):329-34. PubMed ID: 16039819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Resistance of causative agents of uncomplicated urinary tract infections in Russia].
    Rafal'skiĭ VV; Strachunskiĭ LS; Babkin PA; Valenskaia VS; Gabbasova LA; Dmitrieva OB; Emel'ianova IV; Krupin VN; Malev IV; Petrov SB; Rokhlikov IM; Furletova NM; Khaĭrullov AS
    Urologiia; 2006; (5):34-7. PubMed ID: 17444150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does antimicrobial use increase the rate of antimicrobial resistance? A one year experience.
    Gedik H
    Indian J Med Microbiol; 2012; 30(2):198-202. PubMed ID: 22664437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial susceptibility of Gram-negative nonurinary bacteria to fosfomycin and other antimicrobials.
    Samonis G; Maraki S; Rafailidis PI; Kapaskelis A; Kastoris AC; Falagas ME
    Future Microbiol; 2010 Jun; 5(6):961-70. PubMed ID: 20521939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fosfomycin: an old--new antibiotic.
    Raz R
    Clin Microbiol Infect; 2012 Jan; 18(1):4-7. PubMed ID: 21914036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversibility of antimicrobial resistance in respiratory isolates in HIV-positive Cambodian children after 36 months of HAART.
    Shahum A; Benca G; Duong LS; Augustin A; Havlik S; Liska A; Kalavsky E; Beno P; Krcmery V
    J Antimicrob Chemother; 2007 Jul; 60(1):194-7. PubMed ID: 17545143
    [No Abstract]   [Full Text] [Related]  

  • 38. Trends in paediatric and adult bloodstream infections at a Ghanaian referral hospital: a retrospective study.
    Obeng-Nkrumah N; Labi AK; Addison NO; Labi JE; Awuah-Mensah G
    Ann Clin Microbiol Antimicrob; 2016 Aug; 15(1):49. PubMed ID: 27539221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative activity of meropenem in US medical centers (2007): initiating the 2nd decade of MYSTIC program surveillance.
    Jones RN; Kirby JT; Rhomberg PR
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):203-13. PubMed ID: 18329835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial resistance in Europe and its potential impact on empirical therapy.
    Rossolini GM; Mantengoli E
    Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():2-8. PubMed ID: 19040461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.